Vimarsana
Biggest News Aggregation in the World

Page 11 - Dave Ricks News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Dave Ricks. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Dave Ricks Today - Breaking & Trending Today

Jim Cramer's 4 stock ideas from JPMorgan Healthcare Conference - Vimarsana News

Jim Cramer's 4 stock ideas from JPMorgan Healthcare Conference

Health care may be a real challenger to tech this year, a business that can actually grow faster than most of tech.

Source: cnbc.com
Eli Lilly's plans for growth push stock to another new high — plus two more health stock updates - Vimarsana News

Eli Lilly's plans for growth push stock to another new high — plus two more health stock updates

Eli Lilly has no plans to ease up on R&D spending. Meanwhile, Danaher continues to await an 'inflection point,' while GE Healthcare touts its AI opportunity.

Source: cnbc.com
Eli Lilly shares rise on new DTC service for drugs. Cramer says hold on - Vimarsana News

Eli Lilly shares rise on new DTC service for drugs. Cramer says hold on

The latest catalyst for Eli Lilly is a corporate decision more common in the retail and entertainment industries, not pharmaceuticals.

Source: cnbc.com
Eli Lilly Ready To Manufacture New Weight Loss Drug - Vimarsana News

Eli Lilly Ready To Manufacture New Weight Loss Drug

Eli Lilly is marking a year of momentum as they continue into the final phases of testing and trials of its latest drug they say will help millions of people who struggle with obesity.

Source: wibc.com
Eli Lilly's Weight-Loss Drug Zepbound Is Cheaper Than Wegovy - Vimarsana News

Eli Lilly's Weight-Loss Drug Zepbound Is Cheaper Than Wegovy

Eli Lilly priced its new weight-loss drug Zepbound 20% lower than competitor Wegovy, an unusual move in the pharmaceutical world.